logo

For the Inventor, By the Inventor

Raleigh, NC, United States of America

Joshua G Pierce

This inventor holds 6 USPTO granted patents and 4 published patent applications. Top assignees: North Carolina State University, University of South Carolina. Active years: 2020-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joshua G Pierce. Retrieved from https://idiyas.com/inventor/joshua-g-pierce

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0

Average Co-Inventor Count = 2.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal6 out of 1,489 
 
North Carolina State University
 patents
silverMedal1 out of 701 
 
University of South Carolina
 patents
where one patent can have more than one assignee

Years Active: 2020-2023

Loading Chart...
6 patents (USPTO):Explore Patents
1. 11673869 - 4-oxazolidinone antimicrobial agents (2023-06-13),
2. 11555047 - One-step synthesis of phosphate-based inhibitors and applications thereof (2023-01-17),
3. 11370812 - Materials and methods for detection and quantification of β-N-methylamino-L-alanine (2022-06-28),
4. 11352333 - 5-benzylidene-4-oxazolidinones (2022-06-07),
5. 10844025 - 4-oxazolidinone antimicrobial agents (2020-11-24),
6. 10822315 - 5-benzylidene-4-oxazolidinones (2020-11-03),

Title: Innovations and Contributions of Inventor Joshua G. Pierce

Introduction

Joshua G. Pierce is a notable inventor based in Raleigh, NC (US). He has made significant contributions to the field of antimicrobial agents and enzyme inhibitors. With a total of 6 patents, his work has the potential to impact various medical applications.

Latest Patents

One of his latest patents involves the development of 4-oxazolidinone antimicrobial agents. These oxazolidinone derivatives exhibit antimicrobial activity and can modulate biofilms, making them effective against Gram-positive bacteria, including methicillin-resistant strains. Another significant patent is focused on a one-step synthesis of phosphate-based inhibitors. This method involves reacting o-phosphorylethanolamine with an acyl chloride under acidic conditions, leading to the formation of enzyme inhibitors that can be used in pharmaceutical compositions for treating diseases caused by kinetoplastid parasites.

Career Highlights

Joshua has worked with esteemed institutions such as North Carolina State University and the Medical University of South Carolina. His research has contributed to advancements in the understanding and treatment of various diseases.

Collaborations

He has collaborated with notable colleagues, including Jonathan J. Mills and Grant A. Edwards, enhancing the scope and impact of his research.

Conclusion

Joshua G. Pierce's innovative work in antimicrobial agents and enzyme inhibitors showcases his dedication to advancing medical science. His contributions are poised to make a significant difference in the treatment of infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…